Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing 6 stone (38kg) on Mounjaro is a realistic target for some people, but no honest answer comes with a single number. Clinical trial data show average body-weight reductions of around 20–21% at the highest dose over 72 weeks — for someone starting at, say, 19 stone, that lands close to 4 stone. Reaching 6 stone of loss typically requires a higher starting weight, a sustained response to treatment, and time well beyond a year. Mounjaro (tirzepatide) is a prescription-only medicine; whether it is right for you, and at what dose, is a clinical decision made by a prescriber after a full assessment — not something that can be confirmed from a calculator alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the factor most people underestimate. Percentage-based weight loss sounds abstract until you run the numbers. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average reductions of around 20–21% at 15mg over 72 weeks. Apply that to different starting points and you get very different stone figures. Someone weighing 30 stone losing 21% sheds about 6.3 stone, right on target. Someone starting at 22 stone losing the same proportion loses around 4.6 stone. The medicine works proportionally; it does not have a fixed stone-per-month rate that applies to everyone.
Six stone is therefore a realistic ambition for heavier starting weights, and a stretch goal (or beyond current evidence) for lighter ones. A prescriber will look at your weight, your health history and your response at each dose before drawing any conclusions about likely outcomes. That assessment matters precisely because the range of real-world results is wide.
If you want a sense of what different loss targets look like at lower starting weights, our page on losing 4 stone on Mounjaro breaks down the same maths at a closer range.
Most people who reach substantial weight loss on Mounjaro do so over 12–18 months or longer. The reason is partly biological (the body defends its weight actively) and partly structural. Treatment begins at 2.5mg, which is a tolerability dose. Its job is to settle your system, not to drive significant loss. Titration then typically steps up every four weeks, meaning you may not reach your highest tolerated dose until month four or five. Weight loss accelerates as the dose increases, but it is rarely linear.
A rough working model: modest loss in the first couple of months while titrating, faster progress from around month three onward once maintenance doses are reached, then a possible plateau as the body adjusts. People who eventually lose 6 stone on Mounjaro often describe the second half of that loss being slower than the first, and our page on how long it takes to lose 3 stone on Mounjaro gives a useful sense of what reaching the halfway point of a journey like this typically involves. If you are curious about how long it takes to lose 2 stone on Mounjaro, that page explains what the early phase of the titration curve typically looks like. The full explanation of Mounjaro's timeline covers the titration curve in more detail.
The NICE appraisal of tirzepatide (NICE TA1026) uses 72 weeks as the evidence base. If less than 5% has been lost after six months at the highest tolerated dose, continuing treatment is reviewed. Progress, not just the passage of time, is part of the clinical picture.
Trial averages describe groups. Your individual result depends on things no average can capture. Genetics influence how strongly your appetite responds to GIP and GLP-1 receptor activation. Starting metabolic health matters. So does what you eat, not as a moral judgement, but because Mounjaro works with a reduced-calorie diet, not instead of one. Protein intake on a reduced appetite becomes genuinely important; low protein alongside rapid weight loss can mean losing muscle alongside fat, which slows metabolism and makes the second half of a journey to 6 stone harder.
Sleep, stress and activity levels each play a role too. The SURMOUNT-1 participants followed structured lifestyle programmes; their results are not a prediction for someone taking the medicine in isolation. That is not a reason to be pessimistic, it is a reason to use the treatment as the lever it is designed to be, not the whole machine. For context on what a smaller initial target looks like in practice, our page on how long it takes to lose a stone on Mounjaro covers what the very first stage of this journey typically involves.
Costs are a practical factor for many people too. A six-stone loss across 12–18 months means a sustained commitment to treatment, and understanding what private treatment involves financially is sensible planning. Our Mounjaro cost guide sets out what to expect from private prescriptions and what an all-in price should cover.
A 6-stone target is ambitious. That is not a discouragement; it is a reason to make sure the clinical assessment is thorough. At nume, every consultation is read by a GPhC-registered prescriber, a named clinician rather than an automated process. They look at your weight, BMI, health history, any relevant medicines and your goals. If tirzepatide is clinically appropriate, your first pen ships the same day (order before 12pm, Monday to Friday) and arrives the next working day via DPD, tracked, in plain packaging, with the pen itself protected inside a small cool pack.
Repeat prescriptions are re-reviewed before every dispatch. Dose increases require evidence. That structure exists because a goal of this scale is a long-term clinical relationship, not a one-off transaction. If you are weighing up whether Mounjaro or a different treatment fits your situation, the treatment overview sets out the options. Our clinical team brings the same standard of review to every case.
Ready to find out whether treatment is right for you? Start your free consultation and a prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.